In a recent study, an intriguing tumor T-cell metabolic circuit has been identified, wherein tumor-derived lactate disrupts the pyruvate metabolism of CD8+ T cells, consequently impeding the cytotoxicity of these cells [21]. This evidence concerns the gene CD8A and neoplasm.